Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide

Research output: Contribution to journalArticleResearchpeer-review

15 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide'. Together they form a unique fingerprint.

Agriculture & Biology